FDA structure/function "implied" claims proposed ban would alter statute -- NHA.
This article was originally published in The Tan Sheet
STRUCTURE/FUNCTION "IMPLIED" CLAIMS PROPOSED BAN ALTERS STATUTE, the Nutritional Health Alliance says in July 8 comments on FDA's April 29 proposed rule regarding structure/function claims ("The Tan Sheet" May 4, pp. 1-7). By proposing that labeled "reference to a characteristic set of signs or symptoms, even in the absence of the name of the disease, can be understood as a reference to the disease itself," NHA says "the agency is attempting to legislate by ignoring the language" of the Dietary Supplement Health & Education Act and "creating a whole new set of rules which alter and restrict the statutory mandate."
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC